MIRA
INFORM REPORT
|
Report Date : |
02.06.2012 |
IDENTIFICATION DETAILS
|
Name : |
FRANCOPIA SARL |
|
|
|
|
Registered Office : |
174 avenue de France Paris, 75013 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Date of Incorporation : |
15.06.1959 |
|
|
|
|
Com. Reg. No.: |
775662463 |
|
|
|
|
Legal Form : |
Private Subsidiary |
|
|
|
|
Line of Business : |
Wholesale of chemical products |
|
|
|
|
No. of Employees : |
40 |
RATING & COMMENTS
|
MIRAs Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name and address
Francopia SARL
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||
Business Description
|
Francopia is primarily engaged in manufacture of various chemical products:
peptones, peptone derivatives, other protein substances and their derivatives
not elsewhere classified; chemically modified oils and fats; materials used
in the finishing of textiles and leather; powders and pastes used in
soldering, brazing or welding; substances used to pickle metal; prepared
additives for cements; activated carbon, lubricating oil additives, prepared
rubber accelerators, catalysts and other chemical products for industrial
use; anti-knock preparations, anti-freeze preparations, liquids for hydraulic
transmission; and composite diagnostic or laboratory reagents. This class
also includes: manufacture of writing and drawing ink. |
Industry
|
Industry |
Chemical Manufacturing |
|
ANZSIC 2006: |
3323 - Industrial and Agricultural
Chemical Product Wholesaling |
|
NACE 2002: |
5155 - Wholesale of chemical products |
|
NAICS 2002: |
424690 - Other Chemical and Allied
Products Merchant Wholesalers |
|
|
5155 - Wholesale of chemical products |
|
US SIC 1987: |
5169 - Chemicals and Allied Products, Not
Elsewhere Classified |
Key Executives
|
1 - Profit & Loss
Item Exchange Rate: USD 1 = EUR 0.7550783
2 - Balance Sheet Item Exchange Rate: USD 1 = EUR 0.7454064
Corporate Overview
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Corporate Structure News
|
|
|
Francopia SARL |
|
|
|
|
|
|
|
|
Company Name |
Company Type |
Location |
Country |
Industry |
Sales |
Employees |
|
|
Parent |
|
|
Biotechnology and Drugs |
48,746.5 |
113,719 |
||
|
Acquisition of Pluromed, Inc. proposed/announced.See corporate
structure news on Sanofi SA for details |
|||||||
|
Subsidiary |
Frankfurt Am |
|
Commercial Banks |
|
17,023 |
|
|
|
Branch |
Mumbai, |
|
Chemicals - Plastics and Rubber |
|
353 |
|
|
|
Subsidiary |
Frankfurt Am |
|
Real Estate Operations |
|
14 |
|
|
|
Subsidiary |
Frankfurt Am |
|
Chemicals - Plastics and Rubber |
|
3 |
|
|
|
Subsidiary |
Frankfurt Am |
|
Commercial Banks |
|
2 |
|
|
|
Subsidiary |
|
|
Personal and Household Products |
875.0 |
|
|
|
|
Subsidiary |
|
|
Miscellaneous Financial Services |
125.0 |
|
|
|
|
Subsidiary |
|
|
Biotechnology and Drugs |
4,048.7 |
10,000 |
|
|
|
Division |
|
|
Biotechnology and Drugs |
|
8,000 |
|
|
|
Division |
|
|
Biotechnology and Drugs |
1.6 |
7,000 |
|
|
|
Subsidiary |
|
|
Healthcare Facilities |
188.1 |
1,136 |
|
|
|
Division |
|
|
Biotechnology and Drugs |
285.6 |
800 |
|
|
|
Branch |
|
|
Healthcare Facilities |
115.8 |
600 |
|
|
|
Subsidiary |
|
|
Biotechnology and Drugs |
1,097.3 |
453 |
|
|
|
Subsidiary |
Naarden |
|
Biotechnology and Drugs |
984.4 |
450 |
|
|
|
Subsidiary |
|
|
Personal and Household Products |
135.0 |
205 |
|
|
|
Subsidiary |
Neu-Isenburg, Hessen |
|
Personal and Household Products |
186.8 |
200 |
|
|
|
Subsidiary |
Neu-Isenburg, Hessen |
|
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
|
|
Biotechnology and Drugs |
151.7 |
131 |
|
|
|
Subsidiary |
|
|
Biotechnology and Drugs |
34.7 |
37 |
|
|
|
Subsidiary |
Neu-Isenburg, Hessen |
|
Commercial Banks |
|
1 |
|
|
|
Subsidiary |
Geel |
|
Biotechnology and Drugs |
281.1 |
446 |
|
|
|
Branch |
|
|
Biotechnology and Drugs |
|
400 |
|
|
|
Subsidiary |
|
|
Biotechnology and Drugs |
155.4 |
300 |
|
|
|
Branch |
|
|
Business Services |
|
250 |
|
|
|
Subsidiary |
|
|
Biotechnology and Drugs |
|
225 |
|
|
|
Subsidiary |
|
|
Biotechnology and Drugs |
35.0 |
200 |
|
|
|
Subsidiary |
|
|
Biotechnology and Drugs |
|
200 |
|
|
|
Subsidiary |
|
|
Biotechnology and Drugs |
109.2 |
150 |
|
|
|
Branch |
|
|
Biotechnology and Drugs |
|
110 |
|
|
|
Branch |
|
|
Biotechnology and Drugs |
|
100 |
|
|
|
Division |
|
|
Business Services |
|
100 |
|
|
|
Branch |
|
|
Biotechnology and Drugs |
90.4 |
95 |
|
|
|
Division |
|
|
Biotechnology and Drugs |
|
95 |
|
|
|
Subsidiary |
|
|
Biotechnology and Drugs |
|
88 |
|
|
|
Branch |
|
|
Biotechnology and Drugs |
66.6 |
70 |
|
|
|
Subsidiary |
|
|
Biotechnology and Drugs |
1.0 |
70 |
|
|
|
Branch |
|
|
Business Services |
|
60 |
|
|
|
Subsidiary |
|
United States |
Business Services |
6.7 |
50 |
|
|
|
Subsidiary |
Zaventem |
Belgium |
Biotechnology and Drugs |
35.3 |
45 |
|
|
|
Subsidiary |
Copenhagen |
Denmark |
Biotechnology and Drugs |
0.0 |
35 |
|
|
|
Branch |
Exton, PA |
United States |
Biotechnology and Drugs |
9.3 |
18 |
|
|
|
Branch |
San Diego, CA |
United States |
Biotechnology and Drugs |
7.8 |
15 |
|
|
|
Branch |
Cambridge, MA |
United States |
Biotechnology and Drugs |
7.8 |
15 |
|
|
|
Branch |
Philadelphia, PA |
United States |
Biotechnology and Drugs |
6.2 |
12 |
|
|
|
Branch |
Long Beach, CA |
United States |
Healthcare Facilities |
3.4 |
11 |
|
|
|
Subsidiary |
San Antonio, TX |
United States |
Biotechnology and Drugs |
|
10 |
|
|
|
Branch |
Framingham, MA |
United States |
Medical Equipment and Supplies |
5.4 |
9 |
|
|
|
Branch |
Framingham, MA |
United States |
Healthcare Facilities |
1.6 |
8 |
|
|
|
Branch |
Allston, MA |
United States |
Biotechnology and Drugs |
2.1 |
4 |
|
|
|
Branch |
Washington, DC |
United States |
Business Services |
0.6 |
3 |
|
|
|
Division |
Cambridge, MA |
United States |
Scientific and Technical Instruments |
|
3 |
|
|
|
Subsidiary |
Boulogne |
Argentina |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Johannesburg, Bryanston |
South Africa |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Dubai |
United Arab Emirates |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Mexico |
Mexico |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Santiago |
Chile |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Bogota |
Colombia |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Lima |
Peru |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Vienna |
Austria |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Prague |
Czech Republic |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Paris, Saint Germain |
France |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Athens |
Greece |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Kefar Sava |
Israel |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Istanbul |
Turkey |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Gurgaon, Haryana |
India |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Seoul, KangNam-Ku |
Korea, Republic of |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Petaling Jaya, Selangor Darul Ehsan |
Malaysia |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Taipei |
Taiwan |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
North Ryde |
Australia |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Geel |
Belgium |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Madrid |
Spain |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Singapore |
Singapore |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Chilly Mazarin |
France |
Biotechnology and Drugs |
1,783.9 |
6,777 |
|
|
|
Affiliates |
Frankfurt Am Main, Hessen |
Germany |
Biotechnology and Drugs |
6,268.7 |
10,000 |
|
|
|
Subsidiary |
KΓΆln, Nordrhein-Westfalen |
Germany |
Biotechnology and Drugs |
177.7 |
400 |
|
|
|
Subsidiary |
MΓΌnchen, Bayern |
Germany |
Biotechnology and Drugs |
|
45 |
|
|
|
Subsidiary |
Quito |
Ecuador |
Biotechnology and Drugs |
75.0 |
|
|
|
|
Subsidiary |
Bridgewater, NJ |
United States |
Biotechnology and Drugs |
|
10,000 |
|
|
|
Subsidiary |
Kansas City, MO |
United States |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Biotechnology and Drugs |
1,750.0 |
3,000 |
|
|
|
Subsidiary |
Mumbai |
India |
Biotechnology and Drugs |
260.9 |
2,282 |
|
|
|
Branch |
Mumbai, Maharashtra |
India |
Chemical Manufacturing |
|
75 |
|
|
|
Branch |
Mumbai, Maharashtra |
India |
Biotechnology and Drugs |
|
70 |
|
|
|
Branch |
Chennai, Tamil Nadu |
India |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
SΓ£o Paulo, SP |
Brazil |
Biotechnology and Drugs |
1,900.0 |
2,250 |
|
|
|
Subsidiary |
Barcelona |
Spain |
Biotechnology and Drugs |
999.6 |
1,550 |
|
|
|
Subsidiary |
Macquarie Park, NSW |
Australia |
Biotechnology and Drugs |
597.8 |
1,000 |
|
|
|
Subsidiary |
Macquarie Park, NSW |
Australia |
Business Services |
671.6 |
|
|
|
|
Subsidiary |
Mexico |
Mexico |
Biotechnology and Drugs |
250.0 |
1,000 |
|
|
|
Subsidiary |
Laval, QC |
Canada |
Biotechnology and Drugs |
1,170.4 |
800 |
|
|
|
Subsidiary |
Saint-Laurent, QC |
Canada |
Biotechnology and Drugs |
117.2 |
51 |
|
|
|
Subsidiary |
Jakarta |
Indonesia |
Biotechnology and Drugs |
60.0 |
750 |
|
|
|
Subsidiary |
Porto Salvo |
Portugal |
Biotechnology and Drugs |
156.6 |
405 |
|
|
|
Subsidiary |
Bangkok |
Thailand |
Biotechnology and Drugs |
|
350 |
|
|
|
Subsidiary |
Vienna |
Austria |
Biotechnology and Drugs |
|
220 |
|
|
|
Subsidiary |
Gouda |
Netherlands |
Biotechnology and Drugs |
|
160 |
|
|
|
Subsidiary |
Bromma |
Sweden |
Personal and Household Products |
195.2 |
144 |
|
|
|
Subsidiary |
Lima |
Peru |
Personal and Household Products |
25.0 |
120 |
|
|
|
Subsidiary |
Causeway Bay |
Hong Kong |
Personal and Household Products |
18.0 |
100 |
|
|
|
Subsidiary |
Lysaker |
Norway |
Biotechnology and Drugs |
|
90 |
|
|
|
Subsidiary |
Quito |
Ecuador |
Biotechnology and Drugs |
|
70 |
|
|
|
Subsidiary |
Geneva |
Switzerland |
Biotechnology and Drugs |
450.0 |
11 |
|
|
|
Subsidiary |
Lainate, MI |
Italy |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Caracas |
Venezuela |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Amsterdam |
Netherlands |
Biotechnology and Drugs |
914.8 |
6,000 |
|
|
|
Subsidiary |
Hlohovec |
Slovakia |
Biotechnology and Drugs |
243.2 |
996 |
|
|
|
Subsidiary |
Kyiv |
Ukraine |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Duluth, GA |
United States |
Biotechnology and Drugs |
2,700.0 |
5,600 |
|
|
|
Subsidiary |
Harlow |
United Kingdom |
Biotechnology and Drugs |
2,411.0 |
5,235 |
|
|
|
Subsidiary |
Parramatta, NSW |
Australia |
Medical Equipment and Supplies |
69.1 |
95 |
|
|
|
Subsidiary |
Manukau |
New Zealand |
Medical Equipment and Supplies |
2.9 |
39 |
|
|
|
Subsidiary |
Tokyo |
Japan |
Medical Equipment and Supplies |
|
|
|
|
|
Subsidiary |
Lyon |
France |
Biotechnology and Drugs |
963.7 |
1,792 |
|
|
|
Subsidiary |
St Herblon |
France |
Biotechnology and Drugs |
32.5 |
108 |
|
|
|
Subsidiary |
Hallbergmoos, Bayern |
Germany |
Biotechnology and Drugs |
75.9 |
90 |
|
|
|
Subsidiary |
Rio De Mouro, Sintra |
Portugal |
Personal and Household Products |
16.7 |
26 |
|
|
|
Subsidiary |
Velserbroek, Noord-Holland |
Netherlands |
Biotechnology and Drugs |
28.3 |
23 |
|
|
|
Subsidiary |
Shinjuku-Ku, Tokyo |
Japan |
Personal and Household Products |
63.9 |
|
|
|
|
Subsidiary |
Walpole, NH |
United States |
Fish and Livestock |
2.3 |
810 |
|
|
|
Subsidiary |
Sinks Grove, WV |
United States |
Fish and Livestock |
6.1 |
15 |
|
|
|
Subsidiary |
Monroe, OR |
United States |
Crops |
1.6 |
9 |
|
|
|
Subsidiary |
Nanchang City, Jiang Xi |
China |
Crops |
23.0 |
380 |
|
|
|
Subsidiary |
Duluth, GA |
United States |
Biotechnology and Drugs |
19.7 |
300 |
|
|
|
Branch |
Athens, GA |
United States |
Biotechnology and Drugs |
247.5 |
260 |
|
|
|
Subsidiary |
Gainesville, GA |
United States |
Biotechnology and Drugs |
|
250 |
|
|
|
Subsidiary |
El Marques, Queretaro |
Mexico |
Miscellaneous Capital Goods |
5.0 |
200 |
|
|
|
Subsidiary |
Harlow |
United Kingdom |
Personal and Household Products |
108.5 |
192 |
|
|
|
Subsidiary |
Assago, Milano |
Italy |
Chemical Manufacturing |
180.3 |
164 |
|
|
|
Subsidiary |
Halfway House |
South Africa |
Biotechnology and Drugs |
37.0 |
100 |
|
|
|
Subsidiary |
Bogota, Cundinamarca |
Colombia |
Miscellaneous Capital Goods |
35.0 |
100 |
|
|
|
Subsidiary |
Sao Paulo |
Brazil |
Biotechnology and Drugs |
35.0 |
100 |
|
|
|
Subsidiary |
Pasig , Metro Manila |
Philippines |
Biotechnology and Drugs |
8.0 |
100 |
|
|
|
Subsidiary |
Barcelona |
Spain |
Biotechnology and Drugs |
58.5 |
58 |
|
|
|
Subsidiary |
Buenos Aires, Buenos Aires |
Argentina |
Crops |
2.0 |
50 |
|
|
|
Subsidiary |
Singapore |
Singapore |
Crops |
15.0 |
35 |
|
|
|
Subsidiary |
Bruxelles |
Belgium |
Food Processing |
25.2 |
27 |
|
|
|
Branch |
Fulton, MO |
United States |
Biotechnology and Drugs |
19.0 |
20 |
|
|
|
Branch |
Roseville, CA |
United States |
Biotechnology and Drugs |
15.2 |
16 |
|
|
|
Subsidiary |
Antony |
France |
Biotechnology and Drugs |
31.8 |
4,593 |
|
|
|
Subsidiary |
Paris |
France |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Paris |
France |
Biotechnology and Drugs |
1,405.2 |
3,499 |
|
|
|
Subsidiary |
Paris |
France |
Biotechnology and Drugs |
3,565.2 |
3,053 |
|
|
|
Subsidiary |
Strasbourg |
France |
Biotechnology and Drugs |
|
75,000 |
|
|
|
Subsidiary |
Compiègne |
France |
Biotechnology and Drugs |
450.0 |
|
|
|
|
Subsidiary |
Mumbai |
India |
Biotechnology and Drugs |
293.5 |
2,943 |
|
|
|
Subsidiary |
Budapest |
Hungary |
Biotechnology and Drugs |
1,542.6 |
2,500 |
|
|
|
Subsidiary |
MΓ©xico, D.F. |
Mexico |
Biotechnology and Drugs |
385.0 |
2,450 |
|
|
|
Subsidiary |
Maharashtra |
India |
Miscellaneous Capital Goods |
90.0 |
2,450 |
|
|
|
Subsidiary |
Istanbul, Istanbul |
Turkey |
Biotechnology and Drugs |
621.0 |
2,000 |
|
|
|
Branch |
Anthony |
France |
Biotechnology and Drugs |
40.0 |
2,000 |
|
|
|
Subsidiary |
Campinas, SP |
Brazil |
Biotechnology and Drugs |
1,607.7 |
1,615 |
|
|
|
Subsidiary |
Dhaka |
Bangladesh |
Biotechnology and Drugs |
|
1,200 |
|
|
|
Subsidiary |
Plymouth Meeting, PA |
United States |
Biotechnology and Drugs |
146.9 |
1,198 |
|
|
|
Recently acquired (previously owned by BMP Sunstone Corp.).See corporate
structure news on Sanofi SA for details |
|||||||
|
Subsidiary |
Praha |
Czech Republic |
Biotechnology and Drugs |
407.0 |
1,130 |
|
|
|
Subsidiary |
Bucuresti |
|
Biotechnology and Drugs |
82.1 |
522 |
|
|
|
Subsidiary |
Frankfurt |
Germany |
Miscellaneous Capital Goods |
388.0 |
1,000 |
|
|
|
Subsidiary |
Damascus |
Syria |
Biotechnology and Drugs |
27.3 |
25 |
|
|
|
Subsidiary |
SΓ£o Paulo , SΓ£o Paulo |
Brazil |
Miscellaneous Capital Goods |
350.0 |
1,000 |
|
|
|
Subsidiary |
Karachi |
Pakistan |
Biotechnology and Drugs |
88.2 |
777 |
|
|
|
Subsidiary |
Seoul |
Korea, Republic of |
Biotechnology and Drugs |
300.7 |
766 |
|
|
|
Subsidiary |
Midrand |
South Africa |
Biotechnology and Drugs |
150.0 |
750 |
|
|
|
Subsidiary |
Warszawa |
Poland |
Biotechnology and Drugs |
595.7 |
732 |
|
|
|
Subsidiary |
Cairo |
Egypt |
Biotechnology and Drugs |
|
716 |
|
|
|
Subsidiary |
Legaspi Village, Makati , Metro Manila |
Philippines |
Biotechnology and Drugs |
8.0 |
600 |
|
|
|
Subsidiary |
New York, NY |
United States |
Biotechnology and Drugs |
|
600 |
|
|
|
Subsidiary |
Shanghai |
China |
Biotechnology and Drugs |
30.0 |
575 |
|
|
|
Subsidiary |
Chattanooga, TN |
United States |
Biotechnology and Drugs |
463.3 |
547 |
|
|
|
Subsidiary |
Mississauga, ON |
Canada |
Retail (Grocery) |
20.3 |
15 |
|
|
|
Subsidiary |
Basingstoke, Hampshire |
United Kingdom |
Personal and Household Products |
2.5 |
5 |
|
|
|
Branch |
Coral Gables, FL |
United States |
Business Services |
1.2 |
5 |
|
|
|
Branch |
Redondo Beach, CA |
United States |
Business Services |
5.6 |
4 |
|
|
|
Branch |
Chattanooga, TN |
United States |
Retail (Drugs) |
0.7 |
4 |
|
|
|
Branch |
Roseville, CA |
United States |
Retail (Specialty) |
0.6 |
2 |
|
|
|
Subsidiary |
- -, Jakarta |
Indonesia |
Biotechnology and Drugs |
|
500 |
|
|
|
Subsidiary |
Casablanca |
Morocco |
Biotechnology and Drugs |
107.0 |
450 |
|
|
|
Subsidiary |
Casablanca |
Morocco |
Biotechnology and Drugs |
|
450 |
|
|
|
Subsidiary |
Seoul |
Korea, Republic of |
Personal and Household Products |
317.9 |
425 |
|
|
|
Subsidiary |
Virginia, QLD |
Australia |
Biotechnology and Drugs |
29.2 |
400 |
|
|
|
Subsidiary |
San Isidro, Buenos Aires |
Argentina |
Biotechnology and Drugs |
109.3 |
362 |
|
|
|
Subsidiary |
Moscow |
Russian Federation |
Biotechnology and Drugs |
90.0 |
350 |
|
|
|
Subsidiary |
Jeddah, Makkah |
Saudi Arabia |
Biotechnology and Drugs |
60.0 |
350 |
|
|
|
Subsidiary |
Ho Chi Minh City |
Viet Nam |
Biotechnology and Drugs |
12.0 |
350 |
|
|
|
Subsidiary |
Megrine |
Tunisia |
Biotechnology and Drugs |
|
315 |
|
|
|
Subsidiary |
Meyrin |
Switzerland |
Personal and Household Products |
75.0 |
270 |
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Biotechnology and Drugs |
85.0 |
265 |
|
|
|
Subsidiary |
Diegem |
Belgium |
Biotechnology and Drugs |
338.1 |
257 |
|
|
|
Subsidiary |
MΓ©xico |
Mexico |
Healthcare Facilities |
20.0 |
250 |
|
|
|
Subsidiary |
Petaling Jaya, Selangor |
Malaysia |
Biotechnology and Drugs |
63.7 |
200 |
|
|
|
Subsidiary |
Budapest |
Hungary |
Biotechnology and Drugs |
30.0 |
200 |
|
|
|
Subsidiary |
Istanbul |
Turkey |
Biotechnology and Drugs |
621.0 |
185 |
|
|
|
Subsidiary |
Beirut |
Lebanon |
Biotechnology and Drugs |
75.0 |
150 |
|
|
|
Subsidiary |
Wien |
Austria |
Biotechnology and Drugs |
161.0 |
148 |
|
|
|
Subsidiary |
Budapest |
Hungary |
Biotechnology and Drugs |
|
140 |
|
|
|
Subsidiary |
Singapore |
Singapore |
Biotechnology and Drugs |
1,018.5 |
131 |
|
|
|
Subsidiary |
Dublin |
Ireland |
Biotechnology and Drugs |
105.7 |
102 |
|
|
|
Subsidiary |
BogotΓ‘ DC |
Colombia |
Personal and Household Products |
179.8 |
100 |
|
|
|
Subsidiary |
Sofia |
Bulgaria |
Biotechnology and Drugs |
39.0 |
100 |
|
|
|
Subsidiary |
In Lamas Urbanizacion La Castellana, Caracas |
Venezuela |
Miscellaneous Capital Goods |
30.0 |
100 |
|
|
|
Subsidiary |
Las Condes, Santiago |
Chile |
Biotechnology and Drugs |
8.0 |
100 |
|
|
|
Subsidiary |
Taipei |
Taiwan |
Biotechnology and Drugs |
1.0 |
100 |
|
|
|
Subsidiary |
Paris |
France |
Biotechnology and Drugs |
|
100 |
|
|
|
Subsidiary |
Dublin |
Ireland |
Biotechnology and Drugs |
83.4 |
88 |
|
|
|
Subsidiary |
Dublin |
Ireland |
Personal and Household Products |
29.1 |
22 |
|
|
|
Subsidiary |
Horsholm |
Denmark |
Biotechnology and Drugs |
71.0 |
85 |
|
|
|
Subsidiary |
Dakar |
Senegal |
Personal and Household Products |
|
80 |
|
|
|
Subsidiary |
Amman |
Jordan |
Biotechnology and Drugs |
27.0 |
70 |
|
|
|
Subsidiary |
Lysaker, Akershus |
Norway |
Biotechnology and Drugs |
70.3 |
51 |
|
|
|
Subsidiary |
Paris |
France |
Personal and Household Products |
70.4 |
50 |
|
|
|
Subsidiary |
Taipei |
Taiwan |
Personal and Household Products |
22.5 |
50 |
|
|
|
Subsidiary |
Vilnius |
Lithuania |
Biotechnology and Drugs |
2.0 |
50 |
|
|
|
Subsidiary |
San Diego, CA |
United States |
Biotechnology and Drugs |
21.4 |
46 |
|
|
|
Subsidiary |
Singapore |
Singapore |
Biotechnology and Drugs |
94.9 |
39 |
|
|
|
Subsidiary |
Orlando, FL |
United States |
Business Services |
|
30 |
|
|
|
Subsidiary |
Montevideo |
Uruguay |
Retail (Drugs) |
|
30 |
|
|
|
Subsidiary |
Paris |
France |
Business Services |
0.0 |
28 |
|
|
|
Subsidiary |
South San Francisco, CA |
United States |
Business Services |
|
20 |
|
|
|
Subsidiary |
St Germain En Laye |
France |
Personal and Household Products |
261.1 |
14 |
|
|
|
Subsidiary |
Lyon |
France |
Biotechnology and Drugs |
189.5 |
224 |
|
|
|
Subsidiary |
Riga |
Latvia |
Biotechnology and Drugs |
2.0 |
14 |
|
|
|
Subsidiary |
MΓΌlheim-KΓ€rlich, Rheinland-Pfalz |
Germany |
Biotechnology and Drugs |
158.2 |
3 |
|
|
|
Subsidiary |
Frankfurt Am Main, Hessen |
Germany |
Commercial Banks |
|
2 |
|
|
|
Subsidiary |
Paris |
France |
Personal and Household Products |
950.7 |
|
|
|
|
Subsidiary |
Moscow |
Russian Federation |
Personal and Household Products |
682.2 |
|
|
|
|
Subsidiary |
San Isidro |
Argentina |
Biotechnology and Drugs |
75.0 |
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Commercial Banks |
|
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Personal and Household Products |
|
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Commercial Banks |
|
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Nonclassifiable Industries |
|
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Nonclassifiable Industries |
|
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Commercial Banks |
|
|
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Personal and Household Products |
739.4 |
785 |
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Biotechnology and Drugs |
77.6 |
30 |
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Biotechnology and Drugs |
2,081.2 |
420 |
|
|
|
Subsidiary |
Newcastle Upon Tyne |
United Kingdom |
Biotechnology and Drugs |
103.0 |
390 |
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Business Services |
|
|
|
|
|
Subsidiary |
Zagreb |
Croatia |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Warsaw |
Poland |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Bratislava |
Slovakia |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Paris |
France |
Miscellaneous Financial Services |
|
|
|
|
|
Subsidiary |
Antony |
France |
Biotechnology and Drugs |
14,610.7 |
5,472 |
|
|
|
Subsidiary |
Gentilly |
France |
Chemical Manufacturing |
2,146.6 |
4,271 |
|
|
|
Subsidiary |
Paris |
France |
Chemical Manufacturing |
116.7 |
40 |
|
|
|
Subsidiary |
Milano |
Italy |
Biotechnology and Drugs |
1,884.3 |
2,677 |
|
|
|
Subsidiary |
Anagni, FR |
Italy |
Biotechnology and Drugs |
304.3 |
480 |
|
|
|
Subsidiary |
Milano, Milano |
Italy |
Construction and Agriculture Machinery |
0.0 |
1 |
|
|
|
Subsidiary |
Gouda, Zuid-Holland |
Netherlands |
Miscellaneous Capital Goods |
181.4 |
207 |
|
|
|
Subsidiary |
Veghel, Noord-Brabant |
Netherlands |
Biotechnology and Drugs |
|
27 |
|
|
|
Subsidiary |
Helsinki |
Finland |
Personal and Household Products |
108.2 |
113 |
|
|
|
Subsidiary |
Paris |
France |
Miscellaneous Financial Services |
|
|
|
|
|
Subsidiary |
Casablanca |
Morocco |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Santo Domingo |
Dominican Republic |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Mixco |
Guatemala |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Dubai |
United Arab Emirates |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Jakarta |
Indonesia |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Kyiv |
Ukraine |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Nairobi |
Kenya |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Caracas |
Venezuela |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Warsaw |
Poland |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Tashkent |
Uzbekistan |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Algiers |
Algeria |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Antony |
France |
Personal and Household Products |
|
|
|
|
|
Subsidiary |
Lyon |
France |
Biotechnology and Drugs |
2,048.5 |
4,500 |
|
|
|
Subsidiary |
Marcy-l'Etoile, Lyon |
France |
Business Services |
|
8,000 |
|
|
|
Subsidiary |
Swiftwater, PA |
United States |
Biotechnology and Drugs |
554.0 |
4,000 |
|
|
|
Branch |
Taylor, PA |
United States |
Personal and Household Products |
20.9 |
15 |
|
|
|
Branch |
Alpharetta, GA |
United States |
Personal and Household Products |
2.8 |
2 |
|
|
|
Subsidiary |
Lyon, Rouen |
France |
Business Services |
|
1,500 |
|
|
|
Subsidiary |
Toronto, ON |
Canada |
Biotechnology and Drugs |
12.7 |
1,100 |
|
|
|
Subsidiary |
SΓ£o Paulo , SΓ£o Paulo |
Brazil |
Miscellaneous Capital Goods |
150.0 |
750 |
|
|
|
Subsidiary |
North Ryde, NSW |
Australia |
Biotechnology and Drugs |
|
400 |
|
|
|
Subsidiary |
Chaoyang District, Beijing |
China |
Miscellaneous Capital Goods |
102.0 |
350 |
|
|
|
Subsidiary |
Cambridge |
United Kingdom |
Biotechnology and Drugs |
18.8 |
206 |
|
|
|
Subsidiary |
Cambridge, MA |
United States |
Biotechnology and Drugs |
|
160 |
|
|
|
Subsidiary |
San Isidro, Buenos Aires |
Argentina |
Biotechnology and Drugs |
|
130 |
|
|
|
Subsidiary |
Istanbul, Istanbul |
Turkey |
Biotechnology and Drugs |
30.0 |
100 |
|
|
|
Subsidiary |
Moscow |
Russian Federation |
Biotechnology and Drugs |
27.0 |
100 |
|
|
|
Subsidiary |
Lumpini, Pathumwan, Bangkok |
Thailand |
Biotechnology and Drugs |
27.0 |
100 |
|
|
|
Subsidiary |
Jakarta |
Indonesia |
Biotechnology and Drugs |
24.0 |
100 |
|
|
|
Subsidiary |
Manila, Makati |
Philippines |
Biotechnology and Drugs |
27.0 |
70 |
|
|
|
Subsidiary |
Mexico |
Mexico |
Biotechnology and Drugs |
|
65 |
|
|
|
Branch |
Bogota, Cundinamarca |
Colombia |
Biotechnology and Drugs |
15.0 |
55 |
|
|
|
Subsidiary |
Santiago |
Chile |
Biotechnology and Drugs |
29.0 |
45 |
|
|
|
Subsidiary |
Seoul |
Korea, Republic of |
Personal and Household Products |
26.9 |
35 |
|
|
|
Subsidiary |
Istanbul |
Turkey |
Biotechnology and Drugs |
|
35 |
|
|
|
Subsidiary |
SΓ£o Paulo, SP |
Brazil |
Biotechnology and Drugs |
|
30 |
|
|
|
Subsidiary |
Abidjan |
Cote d'Ivoire |
Personal and Household Products |
|
26 |
|
|
|
Subsidiary |
West Toronto, ON |
Canada |
Biotechnology and Drugs |
|
10 |
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Commercial Banks |
|
2 |
|
|
|
Subsidiary |
Guildford |
United Kingdom |
Biotechnology and Drugs |
11.3 |
2 |
|
|
|
Subsidiary |
Hyderabad, |
India |
Biotechnology and Drugs |
38.8 |
|
|
|
|
Subsidiary |
New Delhi |
India |
Biotechnology and Drugs |
1.0 |
|
|
|
|
Subsidiary |
Riga |
Latvia |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Budapest |
Hungary |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Ho Chi Minh City |
Viet Nam |
Chemical Manufacturing |
|
|
|
|
|
Subsidiary |
Shenzhen |
China |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Singapore |
Singapore |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Taipei |
Taiwan |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Sofia |
Bulgaria |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Kuala Lumpur |
Malaysia |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Beijing |
China |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Paris |
France |
Miscellaneous Financial Services |
|
|
|
|
|
Subsidiary |
Makati City |
Germany |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Panama |
Panama |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Porto Salvo |
Portugal |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Asuncion |
Paraguay |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Bucharest |
Romania |
Biotechnology and Drugs |
|
|
|
|
|
Joint Venture |
Beijing, Beijing |
China |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Lima |
Peru |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Tokyo |
Japan |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Prague |
Czech Republic |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Tallinn |
Estonia |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Athens |
Greece |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Goa |
India |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Tegucigalpa |
Honduras |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Ljubljana |
Slovenia |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Manama |
Bahrain |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Quarry Bay, Hong Kong Island |
Hong Kong |
Biotechnology and Drugs |
|
|
|
|
|
Subsidiary |
Beijing |
China |
Personal and Household Products |
|
|
|
|
|
Sanofi-Aventis Research & Development |
Subsidiary |
|
|
|
|
|
|
|
Subsidiary |
Bridgewater, NJ |
United States |
Biotechnology and Drugs |
2,700.0 |
16,508 |
|
|
|
Branch |
Bridgewater, NJ |
United States |
Retail (Drugs) |
91.5 |
500 |
|
|
|
Branch |
Malvern, PA |
United States |
Biotechnology and Drugs |
|
500 |
|
|
|
Division |
Kansas City, MO |
United States |
Personal and Household Products |
417.9 |
300 |
|
|
|
Branch |
St Louis, MO |
United States |
Business Services |
12.5 |
90 |
|
|
|
Branch |
Cambridge, MA |
United States |
Retail (Drugs) |
14.6 |
80 |
|
|
|
Branch |
Forest Park, GA |
United States |
Commercial Banks |
|
60 |
|
|
|
Branch |
Oro Valley, AZ |
United States |
Biotechnology and Drugs |
|
40 |
|
|
|
Branch |
Scottsdale, AZ |
United States |
Personal and Household Products |
44.6 |
32 |
|
|
|
Branch |
Reston, VA |
United States |
Personal and Household Products |
20.9 |
15 |
|
|
|
Branch |
Atlanta, GA |
United States |
Personal and Household Products |
20.9 |
15 |
|
|
|
Branch |
Cambridge, MA |
United States |
Retail (Drugs) |
1.8 |
10 |
|
|
|
Branch |
Bridgewater, NJ |
United States |
Schools |
|
7 |
|
|
|
Branch |
Greenville, DE |
United States |
Business Services |
0.3 |
3 |
|
|
|
Subsidiary |
Malvern, PA |
United States |
Business Services |
|
|
|
|
Executives Report
|
Annual Profit & Loss
|
|
31-Dec-2010 |
31-Dec-2009 |
31-Dec-2008 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate
(Period Average) |
0.755078 |
0.719047 |
0.683679 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Total income |
112.8 |
111.7 |
85.7 |
|
Net sales |
116.7 |
100.7 |
88.3 |
|
Change in stock |
1.9 |
0.6 |
- |
|
Unfinished work in progress |
- |
9.5 |
- |
|
Supplementary operating income |
1.2 |
1.5 |
0.5 |
|
Other operating income |
- |
0.0 |
- |
|
Other external charges |
71.1 |
70.8 |
62.9 |
|
Cost of goods sold |
27.8 |
31.4 |
20.3 |
|
Taxes and social security costs |
0.4 |
0.3 |
0.2 |
|
Cost of stock depreciation and amortisation |
0.6 |
1.9 |
1.0 |
|
Fixed asset depreciation and amortisation |
0.0 |
0.0 |
0.0 |
|
Other operating costs |
0.2 |
0.0 |
- |
|
Total operating costs |
102.0 |
105.0 |
83.2 |
|
Net operating income |
10.8 |
6.7 |
2.5 |
|
Joint venture results |
8.4 |
5.6 |
1.6 |
|
Total financial income |
1.8 |
1.4 |
1.8 |
|
Interest payable on loans |
0.5 |
0.8 |
4.2 |
|
Other expenses |
1.8 |
0.6 |
1.5 |
|
Total expenses |
2.3 |
1.4 |
5.7 |
|
Profit before tax |
2.0 |
1.1 |
0.1 |
|
Extraordinary income |
0.1 |
0.5 |
0.3 |
|
Extraordinary expenses |
0.1 |
0.2 |
0.7 |
|
Extraordinary result |
- |
0.3 |
- |
|
Total taxation |
0.8 |
0.9 |
0.7 |
|
Net profit |
1.2 |
0.5 |
- |
|
Net loss |
- |
- |
1.1 |
|
|
|
Annual Balance
Sheet |
|
Financials in:
USD (mil) |
|
|
|
|
|
31-Dec-2010 |
31-Dec-2009 |
31-Dec-2008 |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.745406 |
0.696986 |
0.719399 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Issued capital |
17.2 |
18.4 |
17.8 |
|
Legal reserves |
0.0 |
0.0 |
0.0 |
|
Total reserves |
0.8 |
0.8 |
0.8 |
|
Profits for the year |
1.2 |
0.5 |
- |
|
Total stockholders equity |
17.8 |
17.8 |
16.7 |
|
Provisions and allowances |
0.8 |
0.9 |
1.2 |
|
Trade creditors |
14.5 |
16.9 |
11.5 |
|
Bank loans and overdrafts |
0.5 |
0.0 |
0.2 |
|
Current bank debts |
- |
0.0 |
- |
|
Other loans |
75.8 |
- |
72.8 |
|
Other liabilities |
8.5 |
79.3 |
- |
|
Taxation and social security |
3.2 |
0.3 |
0.1 |
|
Total current liabilities |
- |
96.4 |
- |
|
Total debts |
102.5 |
96.5 |
84.7 |
|
Regularisation account |
0.3 |
0.3 |
0.1 |
|
Total liabilities (including net worth) |
121.4 |
115.5 |
102.7 |
|
Other fixed assets |
0.0 |
0.1 |
0.0 |
|
Total non-current assets |
0.0 |
0.1 |
0.0 |
|
Prepayments |
0.1 |
0.1 |
0.1 |
|
Net stocks and work in progress |
74.3 |
86.4 |
75.2 |
|
Trade debtors |
46.0 |
27.0 |
20.8 |
|
Other receivables |
0.2 |
1.7 |
5.9 |
|
Prepaid expenses |
0.0 |
0.0 |
0.0 |
|
Cash and liquid assets |
0.6 |
0.2 |
0.0 |
|
Total current assets |
121.3 |
115.4 |
102.1 |
|
Prepaid expenses and deferred costs |
0.1 |
0.0 |
0.5 |
|
Total assets |
121.4 |
115.5 |
102.7 |
|
|
|
Annual Ratios |
|
Financials in:
USD (mil) |
|
|
|
|
|
31-Dec-2010 |
31-Dec-2009 |
31-Dec-2008 |
|
Period Length |
12 Months |
12 Months |
12 Months |
|
Filed Currency |
EUR |
EUR |
EUR |
|
Exchange Rate |
0.745406 |
0.696986 |
0.719399 |
|
Consolidated |
No |
No |
No |
|
|
|
|
|
|
Current ratio |
- |
1.20 |
- |
|
Quick ratio |
- |
0.30 |
- |
|
Total liabilities to net worth |
5.80% |
5.45% |
5.22% |
|
Net worth to total assets |
0.15% |
0.15% |
0.16% |
|
Collection period |
118.20 |
78.70 |
75.30 |
|
Stock turnover rate |
1.60 |
1.20 |
1.10 |
|
Asset turnover |
0.97% |
0.90% |
0.82% |
|
Profit margin |
0.02% |
0.01% |
0.00% |
|
Return on assets |
0.02% |
0.01% |
0.00% |
|
Shareholders' return |
0.11% |
0.07% |
0.01% |
|
Net worth |
17.8 |
17.8 |
16.7 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.92 |
|
|
1 |
Rs.86.03 |
|
Euro |
1 |
Rs.69.13 |
INFORMATION DETAILS
|
Report Prepared
by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SCs credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.